Keynote leadership
Global Vaccine Leadership Summit 2027 — London, 20 May and Boston, 15–16 September
United Kingdom
London
Co-located with Pharmacovigilance Europe 2027
Leadership, collaboration and the future of global vaccine innovation.
Explore London
United States
Boston
Co-located with Pharmacovigilance Americas 2027
Connecting vaccine leadership across science, policy and industry.
Explore BostonProud Sponsor
EVAWG Wiltshire Summit 2026Attended by Her Majesty The Queen
Graviton International, organiser of the Global Vaccine Leadership Summit, was a proud sponsor of the summit.
Graviton International is proud to have sponsored the EVAWG Wiltshire Summit 2026 at Marlborough College on 23 October 2026, attended by Her Majesty The Queen.
Convened by The EVAWG Wiltshire Coalition, the summit brought together people working to end violence against women and girls. Graviton International's support reflects our commitment to using our platforms and networks for causes that matter to the communities we are part of.
As part of our wider community commitment, Graviton International supports local, national and international initiatives.
The EVAWG Wiltshire Coalition (opens in a new tab) →The Summit
Where the global vaccine community comes together.
The Global Vaccine Leadership Summit convenes senior leaders shaping vaccine research, development, manufacturing, regulation, safety, access and public health — from industry, government, regulators, academia and global health.
- More than 80 senior leaders
- 80+
- More than 20 countries
- 20+
- Two global cities
- 2
London Summit Chair
Dr Bassam Hallis OBE
Deputy Director, Head of Vaccine Development & Evaluation Centre, UK Health Security Agency. Chair of the Global Vaccine Leadership Summit London 2027.
Leadership
Ideas that shape the future.
GVLS brings together the leaders responsible for scientific innovation, policy, regulation, vaccine safety, manufacturing, access and delivery.
Discover the summitWhy GVLS
Five themes. One shared purpose.
Leadership
Connecting decision-makers across the vaccine ecosystem.
Science
Exploring advances shaping vaccine discovery and development.
Safety
Strengthening vaccine safety, surveillance and public confidence.
Access
Addressing equitable access and global delivery.
Partnership
Creating relationships capable of accelerating progress.
Connection
The conversations beyond the stage matter just as much.
Purposeful networking. New perspectives. Relationships that continue beyond the summit.
Join the conversationTwo global editions
Two cities.
One global conversation.
London and Boston connect European and American vaccine leadership within one international platform.
Who attends
Designed for the people who make decisions.
A senior, invitation-led audience from every part of the vaccine ecosystem — small enough that every conversation counts.
- CEOs
- Presidents
- SVPs
- VPs
- Global Heads
- Directors
- Regulators
- Government leaders
- Public health leaders
- Scientists
- Researchers
- Vaccine manufacturers
- Biotechnology leaders
- Patient safety leaders
- Investors
- Academic leaders
Partnership
Be part of the conversation.
Connect your organisation with an international community of leaders across vaccines, science, policy and global health.
The summit experience
Inside the summit.
Scientific discussion
Depth, not volume.
Executive networking
The conversations that follow.
International collaboration
Relationships across borders.
London · Boston · 2027
Be part of the globalvaccine conversation.
People. Partnerships. Progress.
Insights
Latest from the summit.
Brochure
Request the brochure.
The delegate brochure and partnership prospectus for London and Boston. Complete a short form and the brochure will be sent to you.
Request the brochure (opens in a new tab)Opens a short Google Form in a new tab.